These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 805118)

  • 41. Antimycobacterial activity of UDP-galactopyranose mutase inhibitors.
    Borrelli S; Zandberg WF; Mohan S; Ko M; Martinez-Gutierrez F; Partha SK; Sanders DA; Av-Gay Y; Pinto BM
    Int J Antimicrob Agents; 2010 Oct; 36(4):364-8. PubMed ID: 20678902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biosynthesis of desthiobiotin in cell-free extracts of Escherichia coli.
    Pai CH
    J Bacteriol; 1969 Sep; 99(3):696-701. PubMed ID: 4905533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Accumulation of rifampicin by Mycobacterium aurum, Mycobacterium smegmatis and Mycobacterium tuberculosis.
    Piddock LJ; Williams KJ; Ricci V
    J Antimicrob Chemother; 2000 Feb; 45(2):159-65. PubMed ID: 10660497
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cycloheximide (antibiotic acti-dione) as a fungicide in solid media for growing tubercle bacilli from sputum.
    CORPER HJ; COHN ML
    Antibiot Chemother (Northfield); 1952 Jan; 2(1):12-5. PubMed ID: 24541730
    [No Abstract]   [Full Text] [Related]  

  • 45. Biotin biosynthesis in Mycobacterium tuberculosis: physiology, biochemistry and molecular intervention.
    Salaemae W; Azhar A; Booker GW; Polyak SW
    Protein Cell; 2011 Sep; 2(9):691-5. PubMed ID: 21976058
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An inhibitor of exported Mycobacterium tuberculosis glutamine synthetase selectively blocks the growth of pathogenic mycobacteria in axenic culture and in human monocytes: extracellular proteins as potential novel drug targets.
    Harth G; Horwitz MA
    J Exp Med; 1999 May; 189(9):1425-36. PubMed ID: 10224282
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cloning of the biotin synthetase gene from Bacillus sphaericus and expression in Escherichia coli and Bacilli.
    Ohsawa I; Speck D; Kisou T; Hayakawa K; Zinsius M; Gloeckler R; Lemoine Y; Kamogawa K
    Gene; 1989 Aug; 80(1):39-48. PubMed ID: 2507401
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Biosynthesis of biotin-vitamers by family Enterobacteriaceae.
    Ohsugi M; Imanishi Y; Teraoka T; Nishimura K; Nakao S
    J Nutr Sci Vitaminol (Tokyo); 1990 Oct; 36(5):447-56. PubMed ID: 2097319
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibiotic substances active against M. tuberculosis.
    BUSH MT; DICKINSON HL
    J Pharmacol Exp Ther; 1945 Nov; 85():237-46. PubMed ID: 21007941
    [No Abstract]   [Full Text] [Related]  

  • 50. Cloning, sequencing, and characterization of the Bacillus subtilis biotin biosynthetic operon.
    Bower S; Perkins JB; Yocum RR; Howitt CL; Rahaim P; Pero J
    J Bacteriol; 1996 Jul; 178(14):4122-30. PubMed ID: 8763940
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synergistic activities of antituberculous drugs with cerulenin and trans-cinnamic acid against Mycobacterium tuberculosis.
    Rastogi N; Goh KS; Horgen L; Barrow WW
    FEMS Immunol Med Microbiol; 1998 Jun; 21(2):149-57. PubMed ID: 9685005
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Determining the mode of action of anti-mycobacterial C17 diyne natural products using expression profiling: evidence for fatty acid biosynthesis inhibition.
    Li H; Cowie A; Johnson JA; Webster D; Martyniuk CJ; Gray CA
    BMC Genomics; 2016 Aug; 17(1):621. PubMed ID: 27514659
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [About antibiotic substances against tubercle bacilli].
    HESSE E
    Arztl Wochensch; 1948 Jan; 3(1-2):28. PubMed ID: 18914354
    [No Abstract]   [Full Text] [Related]  

  • 54. In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.
    Kaushik A; Ammerman NC; Tasneen R; Story-Roller E; Dooley KE; Dorman SE; Nuermberger EL; Lamichhane G
    J Antimicrob Chemother; 2017 Aug; 72(8):2320-2325. PubMed ID: 28575382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Experimental studies in vitro on the antituberculous activities of 27753RP (R.P), a semisynthetic derivative of griselimycine. IV. Antituberculous activities of R.P in vitro under various inadequate conditions for the growth of tubercle bacilli].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):43-9. PubMed ID: 6442175
    [No Abstract]   [Full Text] [Related]  

  • 56. BIOTIN BIOSYNTHESIS. I. BIOTIN YIELDS AND BIOTIN VITAMERS IN CULTURES OF PHYCOMYCES BLAKESLEEANUS.
    EISENBERG MA
    J Bacteriol; 1963 Oct; 86(4):673-80. PubMed ID: 14066460
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Variations in tubercle bacillus resistance to antibiotics according to the method of isolation].
    VIALLIER J; LAGER S
    C R Seances Soc Biol Fil; 1955 Nov; 149(21-22):1993-5. PubMed ID: 13317274
    [No Abstract]   [Full Text] [Related]  

  • 58. Prospects for development of new antimycobacterial drugs, with special reference to a new benzoxazinorifamycin, KRM-1648.
    Tomioka H
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):183-8. PubMed ID: 10912623
    [TBL] [Abstract][Full Text] [Related]  

  • 59. In vitro activity of a novel antimycobacterial compound, N-octanesulfonylacetamide, and its effects on lipid and mycolic acid synthesis.
    Parrish NM; Houston T; Jones PB; Townsend C; Dick JD
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1143-50. PubMed ID: 11257028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression, purification, and characterization of BioI: a carbon-carbon bond cleaving cytochrome P450 involved in biotin biosynthesis in Bacillus subtilis.
    Stok JE; De Voss J
    Arch Biochem Biophys; 2000 Dec; 384(2):351-60. PubMed ID: 11368323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.